The first generic version of EpiPen has been approved. FDA granted Teva clearance to sell a potentially cheaper autoinjector

Posted in Biotech

August 16, 2018

Mannkind is the MoviePass of biotech.

Posted in Biotech

August 03, 2018

GlaxoSmithKline is partnering with 23andMe to develop new medicines. The companies will split costs and profits equally, and Glaxo will make a $300 million investment in 23andMe

Posted in Biotech

July 25, 2018

Novartis to spin off Alcon and launch a $5 billion share buyback

Posted in Biotech

June 29, 2018 • 3 min read

Novartis (NYSE:NVS) is back to focusing on being a drug company as they've decided to spin off Alcon and launch a $5 billion share buyback. This announcement comes after years of speculation that Novartis would part ways with Alcon and investors welcomed the news with the stock up ~4% in early trading....